Study | Reason for exclusion |
---|---|
Acosta 2012 | Unable to determine cell counts |
Akamatsu 2007 | Assay cut‐off did not follow manufacturer's recommendations |
Azoulay 2016 | Possible IFI included in case definition; unable to separate |
Badiee 2016 | Assay cut‐off did not follow manufacturer's recommendations |
Bellanger 2011 | Study utilizes 2 cut‐off values for determining positivity of BDG |
Bhaskaran 2017 | Only bronchoalveolar lavage fluid results given |
Boluk 2016 | Included BDG test as part of reference standard |
Brasier 2015 | Unable to determine cell counts |
Calitri 2017 | Unable to determine cell counts |
Dobias 2018 | Study population did not match inclusion guidelines |
Donato 2017 | Study population did not match inclusion guidelines |
Ellis 2008 | Possible IFI included in case definition; unable to separate |
Goudijl 2013 | Assay cut‐off did not follow manufacturer's recommendations |
Guitard 2016 | Unable to determine cell counts |
Han 2015 | Unable to determine cell counts |
Hartl 2018 | Possible IFI included in case definition; unable to separate |
Heyland 2011 | Did not follow EORTC guidelines; questionable patient population |
Hoenigl 2014 | Only bronchoalveolar lavage fluid results given |
Ji 2008 | Unable to determine cell counts |
Kato 2010 | Included BDG as part of reference standard |
Kishimoto 2019 | Study population did not match inclusion guidelines |
Kumar 2018 | Study population did not match inclusion guidelines |
Lahmer 2016c | Unable to determine cell counts |
Lahmer 2017 | Study population did not match inclusion guidelines |
Leon 2009 | Assay cut‐off did not follow manufacturer's recommendations |
Leon 2012 | Unable to determine cell counts |
Levesque 2015 | Unable to determine cell counts |
Levesque 2017 | Unable to determine cell counts |
Matsumara 2011 | Study utilizes 2 cut‐off values for determining positivity of BDG |
McKeating 2018 | Unable to determine patient population |
Metan 2016 | Unable to determine cell counts |
Montagna 2012 | Unable to determine cell counts |
Mutschlechner 2015 | Unable to determine cell counts |
Oz 2014 | Possible IFI included in case definition; unable to separate |
Pazos 2005 | Assay cut‐off did not follow manufacturer's recommendations |
Pazos 2006 | Assay cut‐off did not follow manufacturer's recommendations |
Picardi 2019 | Not a diagnostic accuracy study |
Presterl 2009 | Assay cut‐off did not follow manufacturer's recommendations |
Ramos 2017 | Cannot separate confirmed Candida cases from probable Candida cases |
Rhein 2014 | Only cerebrospinal fluid results given |
Sax 2011 | Did not follow EORTC guidelines |
Shi 2015 | Did not follow EORTC guidelines |
Su 2017 | Did not follow EORTC guidelines |
Sulahian 2014 | Unable to determine cell counts |
Tasaka 2007 | Unable to determine cell counts |
Watanabe 2009 | Assay cut‐off did not follow manufacturer's recommendations |
White 2018 | Unable to determine cell counts |
Wood 2013 | Cannot separate confirmed PJP cases from probable cases |
Yang 2012 | Did not follow EORTC guidelines |
Yu 2010 | Unable to determine cell counts |
Zheng 2017 | Assay cut‐off did not follow manufacturer's recommendations |
BDG: beta‐D‐glucan test; EORTC: European Organization for Research and Treatment of Cancer; IFI: invasive fungal infection; PJP: Pneumocystis jirovecii pneumonia.